doc
Prostate Cancer - Global Drug Forecast and Market Analysis to 2023 for the $8.2 Billion Market
Prostate cancer market was valued at $2.6 billion in 2013 and it is expected to reach $8.3 million, by 2023. It is estimated that the market will grow at a CAGR of 12.4%. This growth will be driven by the label extensions of currently marketed drugs as well as the launch of nine new premium-priced therapies for the treatment of prostate cancer.
- Latest Innovations, Drivers, Restraints, Challenges and Key Events in the industry by 2024
Alcohol consumption and malaria are the possible risk factors for the development of GBM. In addition, neurofibromatosis, tuberous sclerosis, von-hippel-lindau disease, Li-fraumeni syndrome and turcot syndrome are some of the genetic disorders that are associated with increasing incidences of gliomas. Glioblastoma multiforme is a World Health Organization Grade IV tumor that represents 15 to 20% of all primary intracranial tumors.
